181 related articles for article (PubMed ID: 21653687)
21. Benzo[a]pyrene-3,6-dione inhibited VEGF expression through inducing HIF-1alpha degradation.
Li ZD; Liu LZ; Shi X; Fang J; Jiang BH
Biochem Biophys Res Commun; 2007 Jun; 357(2):517-23. PubMed ID: 17442277
[TBL] [Abstract][Full Text] [Related]
22. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
23. Anthracenedione-methionine conjugates are novel topoisomerase II-targeting anticancer agents with favorable drug resistance profiles.
Lee CH; Hsieh MY; Hsin LW; Chen HC; Lo SC; Fan JR; Chen WR; Chen HW; Chan NL; Li TK
Biochem Pharmacol; 2012 May; 83(9):1208-16. PubMed ID: 22306066
[TBL] [Abstract][Full Text] [Related]
24. Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway.
Zhang J; Cao J; Weng Q; Wu R; Yan Y; Jing H; Zhu H; He Q; Yang B
PLoS One; 2010 Nov; 5(11):e13910. PubMed ID: 21085474
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of epigallocatechin-3-gallate on cell proliferation and the expression of HIF-1α and P-gp in the human pancreatic carcinoma cell line PANC-1.
Zhu Z; Wang Y; Liu Z; Wang F; Zhao Q
Oncol Rep; 2012 May; 27(5):1567-72. PubMed ID: 22367292
[TBL] [Abstract][Full Text] [Related]
26. HIF-1alpha modulation by topoisomerase inhibitors in non-small cell lung cancer cell lines.
Choi YJ; Rho JK; Lee SJ; Jang WS; Lee SS; Kim CH; Lee JC
J Cancer Res Clin Oncol; 2009 Aug; 135(8):1047-53. PubMed ID: 19148680
[TBL] [Abstract][Full Text] [Related]
27. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
[TBL] [Abstract][Full Text] [Related]
28. Tanshinone IIA-induced attenuation of lung injury in endotoxemic mice is associated with reduction of hypoxia-inducible factor 1α expression.
Xu M; Cao F; Liu L; Zhang B; Wang Y; Dong H; Cui Y; Dong M; Xu D; Liu Y; Zhao P; Niu W; Li Z
Am J Respir Cell Mol Biol; 2011 Nov; 45(5):1028-35. PubMed ID: 21622293
[TBL] [Abstract][Full Text] [Related]
29. NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1α signal transduction.
Kim KH; Kim D; Park JY; Jung HJ; Cho YH; Kim HK; Han J; Choi KY; Kwon HJ
J Mol Med (Berl); 2015 May; 93(5):499-509. PubMed ID: 25471482
[TBL] [Abstract][Full Text] [Related]
30. ARC-111 inhibits hypoxia-mediated hypoxia-inducible factor-1alpha accumulation.
Meng F; Nguyen XT; Cai X; Duan J; Matteucci M; Hart CP
Anticancer Drugs; 2007 Apr; 18(4):435-45. PubMed ID: 17351396
[TBL] [Abstract][Full Text] [Related]
31. A novel approach to cancer therapy using PX-478 as a HIF-1α inhibitor.
Lee K; Kim HM
Arch Pharm Res; 2011 Oct; 34(10):1583-5. PubMed ID: 22076756
[TBL] [Abstract][Full Text] [Related]
32. Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.
Atwal M; Swan RL; Rowe C; Lee KC; Lee DC; Armstrong L; Cowell IG; Austin CA
Mol Pharmacol; 2019 Oct; 96(4):475-484. PubMed ID: 31399497
[TBL] [Abstract][Full Text] [Related]
33. Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications.
Rapisarda A; Uranchimeg B; Sordet O; Pommier Y; Shoemaker RH; Melillo G
Cancer Res; 2004 Feb; 64(4):1475-82. PubMed ID: 14983893
[TBL] [Abstract][Full Text] [Related]
34. Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II.
Lee KC; Bramley RL; Cowell IG; Jackson GH; Austin CA
Biochem Pharmacol; 2016 Mar; 103():29-39. PubMed ID: 26794000
[TBL] [Abstract][Full Text] [Related]
35. Cap-dependent translation initiation factor, eIF4E, is the target for Ouabain-mediated inhibition of HIF-1α.
Cao J; He L; Lin G; Hu C; Dong R; Zhang J; Zhu H; Hu Y; Wagner CR; He Q; Yang B
Biochem Pharmacol; 2014 May; 89(1):20-30. PubMed ID: 24345331
[TBL] [Abstract][Full Text] [Related]
36. β-glucan from Lentinus edodes inhibits breast cancer progression via the Nur77/HIF-1α axis.
Zhang X; Li T; Liu S; Xu Y; Meng M; Li X; Lin Z; Wu Q; Xue Y; Pan Y; Alitongbieke G
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33245358
[TBL] [Abstract][Full Text] [Related]
37. Sunitinib deregulates tumor adaptation to hypoxia by inhibiting HIF-1alpha synthesis in HT-29 colon cancer cells.
Shin HW; Cho CH; Kim TY; Park JW
Biochem Biophys Res Commun; 2010 Jul; 398(2):205-11. PubMed ID: 20599738
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and structure-activity relationship of (E)-phenoxyacrylic amide derivatives as hypoxia-inducible factor (HIF) 1α inhibitors.
Naik R; Won M; Kim BK; Xia Y; Choi HK; Jin G; Jung Y; Kim HM; Lee K
J Med Chem; 2012 Dec; 55(23):10564-71. PubMed ID: 23153200
[TBL] [Abstract][Full Text] [Related]
39. Development of novel inhibitors targeting HIF-1α towards anticancer drug discovery.
Yewalkar N; Deore V; Padgaonkar A; Manohar S; Sahu B; Kumar P; Jalota-Badhwar A; Joshi KS; Sharma S; Kumar S
Bioorg Med Chem Lett; 2010 Nov; 20(22):6426-9. PubMed ID: 20932758
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of GSK3beta by indirubins restores HIF-1alpha accumulation under prolonged periods of hypoxia/anoxia.
Schnitzer SE; Schmid T; Zhou J; Eisenbrand G; Brüne B
FEBS Lett; 2005 Jan; 579(2):529-33. PubMed ID: 15642371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
